Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Aug 18;16(16):1487-1488.
doi: 10.1080/15384101.2017.1345237. Epub 2017 Jun 26.

Imipridone family on successful TRAIL

Peter M Anderson  1 , Jacob Scott  1
Affiliations
Comment

Imipridone family on successful TRAIL

Peter M Anderson et al. Cell Cycle. .
No abstract available

Keywords: Akt; CHOP; DR5; ERK; TRAIL; apoptosis induction; breast cancer; colon cancer; melanoma.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The R1 aromatic side chain of imipridone derivatives ONC201, ONC206, and ONC212 provides new directions for nanomolar anti-cancer potency via TRAIL with unique characteristics.
See this image and copyright information in PMC

Comment on

References

    1. Allen JE, Kline CL, Prabhu VV, Wagner J, Ishizawa J, Madhukar N, Lev A, Baumeister M, Zhou L, Lulla A, , Stogniew M, Schalop L, Benes C, Kaufman HL, Pottorf RS, Nallaganchu BR, Olson GL, Al-Mulla F, Duvic M, Wu GS, Dicker DT, Talekar MK, Lim B, Elemento O, Oster W, Bertino J, Flaherty K, Wang ML, Borthakur G, Andreeff M, Stein M, El-Deiry WS. Discovery and clinical introduction of first-in-class imipridone ONC201. Oncotarget 2016; 7(45):74380-92; pmid: - PMC - PubMed
    1. Kline CL, Van den Heuvel AP, Allen JE, Prabhu VV, Dicker DT, El-Deiry WS. ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2alpha kinases. Sci Signal 2016; 9(415):ra18; pmid:; https://doi.org/10.1126/scisignal.aac4374 - DOI - PMC - PubMed
    1. Ishizawa J, Kojima K, Dilip A, Ruvolo VR, Carter BZ, Allen JE, Neelapu SS, McDonnell MJ, Talekar MK, El-Diery WS, Kwak LW, Andreeff M. ONC201 exerts p53-independent cytotoxicity through TRAIL and DR5 induction in mantle cell lymphomas. Blood 2013; 122(21):3822.
    1. Prabhu VV, Allen JE, Dicker DT, El-Deiry WS. Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner. Cancer Res 2015; 75(7):1423-32; pmid:; https://doi.org/10.1158/0008-5472.CAN-13-3451 - DOI - PMC - PubMed
    1. Stein MN, Bertino JR, Kaufman HL, Mayer T, Moss R, Silk A, Chan N, Malhotra J, Rodriguez L, Aisner J, , Aiken RD, Haffty BG, DiPaola RS, Saunders T, Zloza A, Damare S, Beckett Y, Yu B, Najmi S, Gabel C, Dickerson S, Zheng L, El-Deiry WS, Allen JE, Stogniew M, Oster W, Mehner JM. First-in-human clinical trial of oral ONC201 in patients with refractory solid tumors. Clin Cancer Res 2017. pmid:; https://doi.org/10.1158/1078-0432.CCR-16-2658 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources